Aurobindo Pharma USA Inc. recalls Clorazepate Dipotassium Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Discoloration: Dotted and yellow spots on tablets
- Products
-
- Clorazepate Dipotassium Tablets
- Company
- Aurobindo Pharma USA Inc.
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 6696 bottles
- About this recall
- Clorazepate Dipotassium Tablets, USP, 3.75 mg, a) 100 tablets per bottle, NDC 13107-282-01 b) 500 tablets per bottle, NDC 13107-282-05, Rx Only, Distributed by Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.